Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of Persistent Chemotherapy-Induced Thrombocytopenia By Ogkologos - March 26, 2026 97 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the RECITE study Source RELATED ARTICLESMORE FROM AUTHOR Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for Localised TNBC ESMO Advocates for Equal Access to Optimal Cancer Care for all Patients with Cancer at the 79th World Health Assembly Daraxonrasib Shows Antitumour Activity Among Patients with Previously Treated RAS-mutated Pancreatic Ductal Adenocarcinoma MOST POPULAR FDA Approves Durvalumab for Muscle Invasive Bladder Cancer May 2, 2025 NCI Expands Repository of Cancer Research Models: A Conversation with Drs.... April 20, 2018 What Is Intuitive Eating and How Can It Help During Cancer? January 31, 2023 How I’m Working to Erase the Stigma of Lung Cancer: A... November 22, 2023 Load more HOT NEWS Can Age Affect Response to Immune Checkpoint Inhibitors? What to Know About At-Home DNA Tests for Detecting Cancer Risk Celebrating 10 years of partnership with ScottishPower and £35m raised Neoadjuvant Nivolumab Plus Chemotherapy Improves OS Among Patients with Resectable NSCLC...
